No article text was recorded for this version.
oncogenic synergy
Version 1 of 163 papers94 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined <i>TP53</i> and <i>PTEN</i> mutations with increased proliferation index, an implication for pathogenesis
- Blog: Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic
- Blog: Mutant SF3B1 promotes PDAC malignancy through TGF-β resistance
- Blog: Follow-up of hereditary endometrial carcinoma caused by MLH3 gene mutation: a case report
- Blog: Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity
- Blog: Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells
- Blog: Deficient Rnf43 potentiates hyperactive Kras‐mediated pancreatic preneoplasia initiation and malignant transformation
- Blog: Co-occurrence of RUNX1 and ASXL1 mutations underlie poor response and outcome for MDS patients treated with HMAs.
- Blog: microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer
- Blog: Genetic Aberrations and Interaction of <i>NEK2</i> and <i>TP53</i> Accelerate Aggressiveness of Multiple Myeloma
- Blog: A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer
- Blog: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
- Blog: Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis
- Blog: FLT3-ITD compared with DNMT3A R882 mutation is a more powerful independent inferior prognostic factor in adult AML patients after Allogeneic Hematopoietic Stem Cell Transplantation: A retrospective cohort study
- Blog: PRIMARY LIVER CANCER : NATURAL TOXINS AND PREVENTION IN CHINA
- Blog: Bayesian inference of fitness landscapes via tree-structured branching processes
- Blog: Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis
- Blog: Loss of epigenetic regulation disrupts lineage integrity, reactivates multipotency and promotes breast cancer
- Blog: CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
- Blog: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
- Blog: Combined deletion of <scp>P</scp> ten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on e <scp>EF</scp> 2 <scp>K</scp>
- Blog: Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells
- Blog: Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
- Blog: Mutant SF3B1 promotes malignancy in PDAC
- Blog: DelSIEVE: cell phylogeny modeling of single nucleotide variants and deletions from single-cell DNA sequencing data
- Blog: Clonal evolution driven by superdriver mutations
- Blog: Early lesions of follicular lymphoma: a genetic perspective
- Blog: FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy
- Blog: Experimental mouse models for translational human cancer research
- Blog: STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs
- Blog: Target sequencing and CRISPR/Cas editing reveal simultaneous loss of <i>UTX</i> and <i>UTY</i> in urothelial bladder cancer
- Blog: Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis
- Blog: Genetic Progression and the Waiting Time to Cancer
- Blog: NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis
- Blog: A Comprehensive Analysis of <i>FGF</i>/<i>FGFR</i> Signaling Alteration in <scp>NSCLC</scp>: Implications in Prognosis and Microenvironment
- Blog: Modeling tumor progression in heterogeneous microenvironments: A cellular automata approach
- Blog: Statistical tests for intra-tumour clonal co-occurrence and exclusivity
- Blog: Status of 10 targeted genes of non‐small cell lung cancer in eastern China: A study of 884 patients based on <scp>NGS</scp> in a single institution
- Blog: Case Report: Management of a BCR-ABL1-positive high-risk rhabdomyosarcoma patient using tyrosine kinase inhibitors
- Blog: The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes
- Blog: Stabilization of HIF-1α and HIF-2α, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model
- Blog: Dynamics of Mutant Cells in Hierarchical Organized Tissues
- Blog: Pan-cancer analysis of homologous recombination deficiency and homologous recombination repair–associated gene alterations in solid tumors from a large Asian cohort
- Blog: Identification of cancer mini-drivers by deciphering selective landscape in the cancer genome
- Blog: Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing
- Blog: ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma
- Blog: Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer
- Blog: Mosaic chromosomal alterations in blood across ancestries via whole-genome sequencing
- Blog: Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma
- Blog: lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations
- Blog: Microsatellite Alterations of Major Tumor Suppressor Genes in Hepatocellular Carcinoma
- Blog: Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort
- Blog: The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1-mutated acute myeloid leukemia
- Blog: Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts
- Blog: Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
- Blog: Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
- Blog: A novel hypergraph model for identifying and prioritizing personalized drivers in cancer
- Blog: A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations
- Blog: Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon
- Blog: Can mutation abundance assess the biological behavior of BRAFV600E-positive papillary thyroid carcinoma?
Showing 60 of 63 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_oncogenic_synergy_c1493e24,
title = {oncogenic synergy},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/oncogenic-synergy/rdr_c1493e241eb3495dad0efc921fba92b9},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_oncogenic_synergy_c1493e24_v1,
title = {oncogenic synergy},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/oncogenic-synergy/rdr_c1493e241eb3495dad0efc921fba92b9/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}